GT200000114A - CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINOFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2, 2-DIMETHYLPROPIONAMIDE. - Google Patents

CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINOFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2, 2-DIMETHYLPROPIONAMIDE.

Info

Publication number
GT200000114A
GT200000114A GT200000114A GT200000114A GT200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A GT 200000114 A GT200000114 A GT 200000114A
Authority
GT
Guatemala
Prior art keywords
phenyl
crystalline form
form iii
dimethylaminoftalen
sulphonylamine
Prior art date
Application number
GT200000114A
Other languages
Spanish (es)
Inventor
Alfonso Grunenberg
Andreas Lender
Andree Folkerts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200000114A publication Critical patent/GT200000114A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/44—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B29/00—Single crystals or homogeneous polycrystalline material with defined structure characterised by the material or by their shape
    • C30B29/54—Organic compounds
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A LA FORMA CRISTALINA III DE LA N(4(5DIMETILAMINONAFTALEN1SULFONILAMINO)FENIL)3 HIDROXI2, 2DIMETILPROPIONAMIDA (REFERIDA EN ADELANTE COMO DNSP), COMPRENDE PROCEDIMIENTOS PARA SU OBTENCION, A FORMULACIONES DE MEDICAMENTOS QUE LA COMPRENDEN Y A SU USO PARA EL TRATAMIENTO O PROFILAXIS DE INFECCIONES VIRICAS Y ENFERMEDADES CAUSADAS POR ESTOS, ESPECIALMENTE PARA EL TRATAMIENTO O PROFILAXIS DE ENFERMEDADES CAUSADAS POR CITOMEGALOVIRUS HUMANO (HCMV).THE INVENTION REFERS TO THE CRYSTALLINE FORM III OF THE N (4 (5DIMETHYLAMINONAFTALEN1SULPHONYLAMINE) PHENYL) 3 HYDROXY2, 2DIMETHYLPROPIONAMIDE (REFERRED IN ADVANCE AS DNSP), UNDERSTANDS PROCEDURES FOR OBTAINING THE COMPLIANCE FOR USE OR PROFILAXIS OF VIRIC INFECTIONS AND DISEASES CAUSED BY THESE, ESPECIALLY FOR THE TREATMENT OR PROFILAXIS OF DISEASES CAUSED BY HUMAN CITOMEGALOVIRUS (HCMV).

GT200000114A 1999-07-21 2000-07-10 CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINOFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2, 2-DIMETHYLPROPIONAMIDE. GT200000114A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19934295A DE19934295A1 (en) 1999-07-21 1999-07-21 New thermodynamically stable crystal modification III of N-phenyl-naphthalene-sulfonamide derivative, is an antiviral agent especially useful for treating cytomegalovirus infections

Publications (1)

Publication Number Publication Date
GT200000114A true GT200000114A (en) 2002-01-01

Family

ID=7915608

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200000114A GT200000114A (en) 1999-07-21 2000-07-10 CRYSTALLINE FORM III OF THE N- (4- (5-DIMETHYLAMINOFTALEN-1-SULPHONYLAMINE) PHENYL) -3-HYDROXI-2, 2-DIMETHYLPROPIONAMIDE.

Country Status (8)

Country Link
AR (1) AR024797A1 (en)
AU (1) AU6562600A (en)
CO (1) CO5180571A1 (en)
DE (1) DE19934295A1 (en)
GT (1) GT200000114A (en)
PE (1) PE20010382A1 (en)
UY (1) UY26251A1 (en)
WO (1) WO2001007404A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780794B2 (en) 2000-01-20 2004-08-24 Honeywell International Inc. Methods of bonding physical vapor deposition target materials to backing plate materials
US6698647B1 (en) 2000-03-10 2004-03-02 Honeywell International Inc. Aluminum-comprising target/backing plate structures
US7371906B2 (en) * 2004-08-24 2008-05-13 Eastman Kodak Company Process for photo-oxidative stability improvements
EP2481540B1 (en) 2011-01-28 2017-11-01 Schelling Anlagenbau GmbH Device for sawing at least two plate or plate stack shaped workpieces

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL341815A1 (en) * 1998-01-23 2001-05-07 Bayer Ag Novel naphtyl- and anilide-susbtituted sulphonamides

Also Published As

Publication number Publication date
AR024797A1 (en) 2002-10-23
PE20010382A1 (en) 2001-06-11
DE19934295A1 (en) 2001-01-25
UY26251A1 (en) 2001-01-31
WO2001007404A1 (en) 2001-02-01
AU6562600A (en) 2001-02-13
CO5180571A1 (en) 2002-07-30

Similar Documents

Publication Publication Date Title
ECSP003589A (en) ORGANIC COMPOUNDS
BRPI0411900B8 (en) compounds and pharmaceutical compositions comprising them
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
BRPI0418251A (en) phosphonates, monophosphonamidates, bisphosphonamidates for the treatment of viral diseases
NO20052512L (en) Purine compounds and use deav as cannabinoid receptor ligands
HN1999000124A (en) SUBSTITUTED PYRAZOLE DERIVATIVES.
ES2146300T3 (en) USE OF ANTIHELMINTIC COMPOSITIONS FOR THE TREATMENT OF INFECTIONS CAUSED BY ANOPLOCEPHALA PERFOLIATA IN EQUIDS.
PA8578601A1 (en) DERIVATIVES OF 2,2- DIFENIL-BENZODIOXOL
ECSP024399A (en) BENZOTIAZOL DERIVATIVES
AR026163A1 (en) USE OF RETIGABINE FOR THE TREATMENT OF NEUROPATIC PAIN
ECSP055980A (en) INDEXOX OXAZOLIDINONES AND DERIVATIVES OF THE SAME
UY30274A1 (en) SUBSTITUTED DERIVATIVES OF THE N- (4-METHYL-1,3-TIAZOL-2-IL) GUANIDINE, PHARMACEUTICAL FORMULATIONS CONTAINING IT AND APPLICATIONS
AR022469A1 (en) USE OF SUBSTITUTED AND DERIVATIVE ISOXAZOLCARBOXILIC ACIDS AND NEW SUBSTANCES
ATE418554T1 (en) 1-ACYL-PYRROLIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS
CR10165A (en) "USE OF BENZO-FUSION HETEROCICLE SULFAMIDE DERIVATIVES FOR DEPRESSION TREATMENT"
ES2421948T3 (en) Compounds and compositions for delivering active agents
ES2187261B2 (en) ETERES AND AMIDAS COMPOUNDS AND THEIR PREPARATION, AS ANTI-DIABETIC AGENTS.
BRPI0417858A (en) compound, pharmaceutical composition, and use of a pharmaceutical composition
BRPI0415203A (en) restructured pentanols, a process for their production and use as anti-inflammatory agents
SE9901077D0 (en) Novel use
UY28313A1 (en) NONADEPSIPEPTIDOS ACILADOS
PA8661701A1 (en) THIAZOLIDINONES, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT
DE60112960D1 (en) CONDENSED PYRIDOINDOL DERIVATIVES
UY28248A1 (en) CHINICAL COMPOUNDS